Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Funayama

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Parkinsonism & Related Disorders|February 21, 2021
Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-upMayu Ishiguro, Yuanzhe Li, Hiroyo Yoshino, et al.
Neuroreport|February 23, 2007
Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian populationManabu Funayama, Yuanzhe Li, Hiroyuki Tomiyama, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 23, 2008
Progress in the pathogenesis and genetics of Parkinson's diseaseYoshikuni Mizuno, Nobutaka Hattori, Shin-Ichiro Kubo, et al.
Parkinsonism & Related Disorders|May 20, 2008
Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, AustraliaGeorge D Mellick, Gerhard A Siebert, Manabu Funayama, et al.
Journal of Human Genetics|March 4, 2011
PLA2G6 variant in Parkinson's diseaseHiroyuki Tomiyama, Hiroyo Yoshino, Kotaro Ogaki, et al.
Parkinsonism & Related Disorders|February 17, 2016
Schizophrenia as a prodromal symptom in a patient harboring SNCA duplicationShogo Takamura, Aya Ikeda, Kenya Nishioka, et al.
Neurology. Genetics|June 18, 2026
Expanding the Spectrum of <i>BCAP31</i>-Associated Diseases: Early-Onset Parkinson DiseaseMayu Ishiguro, Manabu Funayama, Daniel H Park, et al.
Brain Research|July 13, 2010
Impaired in vivo dopamine release in parkin knockout miceGenko Oyama, Kenji Yoshimi, Shihoko Natori, et al.
Nature Communications|June 8, 2017
Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome cHongrui Meng, Chikara Yamashita, Kahori Shiba-Fukushima, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2025
Electroconvulsive Therapy Can Prevent a Worsening of Psychosis and Dystonic Voice in PRKN-associated Parkinson's DiseaseToshiki Tezuka, Kensuke Daida, Shinichiro Nakajima, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Parkinsonism & Related Disorders|February 21, 2021
Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-upMayu Ishiguro, Yuanzhe Li, Hiroyo Yoshino, et al.
Neuroreport|February 23, 2007
Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian populationManabu Funayama, Yuanzhe Li, Hiroyuki Tomiyama, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 23, 2008
Progress in the pathogenesis and genetics of Parkinson's diseaseYoshikuni Mizuno, Nobutaka Hattori, Shin-Ichiro Kubo, et al.
Parkinsonism & Related Disorders|May 20, 2008
Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, AustraliaGeorge D Mellick, Gerhard A Siebert, Manabu Funayama, et al.
Journal of Human Genetics|March 4, 2011
PLA2G6 variant in Parkinson's diseaseHiroyuki Tomiyama, Hiroyo Yoshino, Kotaro Ogaki, et al.
Parkinsonism & Related Disorders|February 17, 2016
Schizophrenia as a prodromal symptom in a patient harboring SNCA duplicationShogo Takamura, Aya Ikeda, Kenya Nishioka, et al.
Neurology. Genetics|June 18, 2026
Expanding the Spectrum of <i>BCAP31</i>-Associated Diseases: Early-Onset Parkinson DiseaseMayu Ishiguro, Manabu Funayama, Daniel H Park, et al.
Brain Research|July 13, 2010
Impaired in vivo dopamine release in parkin knockout miceGenko Oyama, Kenji Yoshimi, Shihoko Natori, et al.
Nature Communications|June 8, 2017
Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome cHongrui Meng, Chikara Yamashita, Kahori Shiba-Fukushima, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2025
Electroconvulsive Therapy Can Prevent a Worsening of Psychosis and Dystonic Voice in PRKN-associated Parkinson's DiseaseToshiki Tezuka, Kensuke Daida, Shinichiro Nakajima, et al.
Pageof 10